Projects per year
Personal profile
Education/Academic qualification
chemistry, Bachelor
chemistry, master
Fingerprint
Dive into the research topics where Leo Heyndrickx is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
CUBA - 2018 - FA4: To strengthen Institute of Tropical Medicine Pedro Kouri (IPK, Cuba) and National Institute of Hygiene, Epidemiology and Microbiology (INHEM, Cuba) towards accomplishment of their academic mission through capacity building and scientific co-operation.
Boelaert, M., Vanlerberghe, V., Battaglioli, T. C. E., De Baetselier, I., de Jong, B., Torrea, G., Ariën, K., Heyndrickx, L. & Everaert, R.
1/01/18 → 31/12/18
Project: Development project
-
SOUTHAFRICA -2018 - FA4: Strengthening the capacity for research, teaching, policy advice, advocacy and networking of the partners in the field of human and animal health (South-Africa).
Dorny, P., Damme, W. V., Marchal, B., Dermauw, V., Rigouts, L., Heyndrickx, L., Van Belle, S. & Debois, D.
1/01/18 → 31/12/18
Project: Development project
-
PERU - FA4: To strengthen the R&D capacities of the Institute of Tropical Medicine Alexander von Humboldt (Peru) to deliver strategies and/or tools for diagnosis, surveillance and control of infectious diseases.
Dujardin, J., Rosanas-Urgell, A., de Jong, B., Ariën, K., Van der Auwera, G., Rigouts, L., Heyndrickx, L., Kattenberg, J. H., Battaglioli, T. C. E., Jacobs, J., Monsieurs, P. & Guetens, P.
1/11/17 → 31/12/21
Project: Development project
Research output
-
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell mediated immunity
McCafferty, S., Haque, A. A., Vandierendonck, A., Weidensee, B., Plovyt, M., Stuchlíková, M., François, N., Valembois, S., Heyndrickx, L., Michiels, J., Ariën, K. K., Vandekerckhove, L., Abdelnabi, R., Foo, C. S., Neyts, J., Sahu, I. & Sanders, N. N., 2022, In : Molecular Therapy.Research output: Contribution to journal › A1: Web of Science-article
-
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients
Canti, L., Ariën, K. K., Desombere, I., Humblet-Baron, S., Pannus, P., Heyndrickx, L., Henry, A., Servais, S., Willems, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Goossens, M. E., Beguin, Y., Marchant, A. & Baron, F., 2022, In : Cancer Cell. 40, 4, p. 335-337 3 p.Research output: Contribution to journal › A1: Web of Science-article
-
Chikungunya virus' high genomic plasticity enables rapid adaptation to restrictive A549 cells
De Caluwé, L., Heyndrickx, L., Coppens, S., Vereecken, K., Quiñones-Mateu, M. E., Merits, A., Ariën, K. K. & Bartholomeeusen, K., 2022, In : Viruses. 14, 2, 15 p., 282.Research output: Contribution to journal › A1: Web of Science-article
Open AccessFile38 Downloads (Pure) -
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant
Ariën, K. K., Heyndrickx, L., Michiels, J., Vereecken, K., Van Lent, K., Coppens, S., Willems, B., Pannus, P., Martens, G. A., Van Esbroeck, M., Goossens, M. E., Marchant, A., Bartholomeeusen, K. & Desombere, I., 2022, In : Vaccines. 7, 1, 3 p., 35.Research output: Contribution to journal › Article
Open AccessFile -
A dynamic mucin mRNA signature associates with COVID-19 disease presentation and severity
Smet, A., Breugelmans, T., Michiels, J., Lamote, K., Arras, W., De Man, J. G., Heyndrickx, L., Hauner, A., Huizing, M., Malhotra-Kumar, S., Lammens, M., Hotterbeekx, A., Kumar-Singh, S., Verstraeten, A., Loeys, B., Verhoeven, V., Jacobs, R., Dams, K., Coenen, S., Ariën, K. K. & 2 others, , 2021, In : JCI insight. 6, 19Research output: Contribution to journal › A1: Web of Science-article